is the fda going to ban compounded semaglutide moving restrict mass-marketed GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Compounded Semaglutide: Legal & Safe

If retatrutide is eventually approved, it will come with proper oversight, evidence-based dosing and medical supervision

Across clinical trials and real-world settings, weight loss remained modest, relapse rates after discontinuation were high, and treatment was often fragmented, lacking integration into interdisciplinary care models

Claims of being a "direct manufacturer" without verifiable evidence

The growth follows a significant May ruling in which the court allowed key expert testimony regarding gastroparesis and other gastrointestinal injuries to proceed, preserving important evidence for plaintiffs as the litigation moves forward

Medications will be delivered to a patients door in seven days from the time of order, according to the company

Medicare GLP-1 Bridge is a short-term CMS demonstration which runs from July 1, 2026 to December 31, 2027